Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination

Vaccine

Volumn 28, Issue 45, 2010, Pages 7319-7330

  Surls, Jacqueline ^a   Nazarov Stoica, Cristina ^a   Kehl, Margaret ^a   Casares, Sofia ^a,b   Brumeanu, Teodor D ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Foxp3+ T regulatory cells; Immune responses; Influenza virus; Vaccination

Indexed keywords

INFLUENZA VACCINE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HELPER CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLUENZA; INFLUENZA VACCINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VIRUS INACTIVATION;

ANIMALS; B-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; VACCINES, INACTIVATED;

EID: 77957753360     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.074     Document Type: Article

References (65)

1. Kilbourne E.D. Influenza 1987, Plenum, New York, p. 234.
2. Townsend A., Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989, 7:601-624.
3. Milligan G.N., Flaherty L., Braciale V.L., Braciale T.J. Nonconventional (TL-encoded) major histocompatibility complex molecules present processed viral antigen to cytotoxic T lymphocytes. J Exp Med 1991, 174:133-138.
4. Zaghouani H., Kuzu Y., Kuzu H., Brumeanu T.D., Steinman R.M., Bona C.A. Contrasting efficacy of presentation by MHC class I and class II products when peptides are administrated within a common protein carrier, self-immunoglobulin. Eur J Immunol 1993, 23:2746.
5. Gordon D, Influenza in man. In: Kilbourne E, editor. The influenza viruses and influenza. New York: Academic press; 1975. p. 395-443.
6. Giamarellos-Bourboulis E.J., Raftogiannis M., Antonopoulou A., Baziaka F., Koutoukas P., Savva A., et al. Effect of the Novel Influenza A (H1N1) virus in the human immune system. PloS ONE 2009, 4(12):e8393. p. 2750.
7. Mills K.H.G., McGuirk P. Antigen-specific regulatory T cells: their induction and role in infection. Seminars Immunol 2004, 16:107-117.
8. Majlessi J., Lo-Man R., Leclerc C. Regulatory B and T cells in infections. Microbes Infect 2008, 10:1030-1035.
9. Vahlenkamp T.W., Tompkins M.B., Tompkins W.A.F. The role of CD4+CD25+ regulatory T cells in viral infections. Veterinary Immunol Immunopathol 2005, 108:219-225.
10. Haeryfar S.M., DiPaolo R.J., Tscharke D.C., Bennink J.R., Yewdell J.W. Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J Immunol 2005, 174:3344-3351.
11. Hurwitz J.L., Hackett C.J. Influenza-specific suppression: contribution of major viral proteins to the generation and function of T suppressor cells. J Immunol 1985, 135:2134-2139.
12. Sun J., Madan R., Karp C.L., Braciale T.J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 2009, 15:277-284.
13. Smith R.H., Ziola B. Cyclophosphamide and dimethyl dioctadecyl ammonium bromide immunopotentiate the delayed-type hypersensitivity response to inactivated enveloped viruses. Immunology 1986, 58(2):245-250.
14. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
15. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
16. Darrasse-Jeze G., Klatzmann D., Charlotte F., Salomon B.L., Cohen J.L. CD4+CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol Lett 2006, 102(1):106-109.
17. Lee MK 4th, Moore DJ, Jarrett BP, Lian MM, Deng S, Huang X, et al. Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 2004; 172:6539-6544.
18. Valzasina B., Piconese S., Guiducci C., Colombo M.P. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. Cancer Res 2006, 66:4488-4495.
19. Levings M.K., Roncarolo M.G. T-regulatory-1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 2000, 106:109-112.
20. McGuirk P., McCann C., Mills K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002, 195:221-231.
21. Plebanski M., Flanagan K.L., Lee E.A., Reece W.H., Hart K., Gelder C., et al. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity 1999, 10:651-660.
22. Lavelle E.C., McNeela E., Armstrong M.E., Leavy O., Higgins S.C., Mills K.H. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol 2003, 171:2384-2392.
23. Suvas S., Azkur A.K., Kim B.S., Kumaraguru U., Rouse B.T. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004, 172:4123-4132.
24. Iwashiro M., Messer R.J., Peterson K.E., Stromnes I.M., Sugie T., Hasenkrug K.J. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci U S A 2001, 98:9226-9230.
25. MacDonald A.J., Duffy M., Brady M.T., McKiernan S., Hall W., Hegarty J., et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 2002, 185:720-727.
26. Sugimoto K., Ikeda F., Stadanlick J., Nunes F.A., Alter H.J., Chang K.M. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003, 38:1437-1448.
27. Cabrera R., Tu Z., Xu Y., Firpi R.J., Rosen H.R., Liu C., et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004, 40:1062-1071.
28. Lund J.M., Hsing L., Pham T.T., Rudensky A.Y. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008, 320(5880):1220-1224.
29. Oswald-Richter K., Grill S.M., Shariat N., Leelawong M., Sundrud M.S., Haas D.W., et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004, 2:E198.
30. Aandahl E.M., Michaelsson J., Moretto W.J., Hecht F.M., Nixon D.F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004, 78:2454-2459.
31. Kinter A.L., Hennessey M., Bell A., Kern S., Lin Y., Daucher M., et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004, 200:331-343.
32. Weiss L., Donkova-Petrini V., Caccavelli L., Balbo M., Carbonneil C., Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004, 104:3249-3256.
33. Karube K., Ohshima K., Tsuchiya T., Yamaguchi T., Kawano R., Suzumiya J., et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol 2004, 126:81-84.
34. Yamano Y., Takenouchi N., Li H.C., Tomaru U., Yao K., Grant C.W., et al. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 2005, 115:1361-1368.
35. Rouse B.T., Sarangi P.P., Suvas S. Regulatory T cells in virus infections. Immunol Rev 2006, 212:272-286.
36. Casares S., Hurtado A., McEvoy R.C., Sarukhan A., von Boehmer H., Brumeanu T.D. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol 2002, 3:383-391.
37. Brumeanu T.-D., Casares S., Bot A., Bona C.A. Immunogenicity of a contiguous T-B synthetic epitope of the PR/8/34 influenza virus. J Virol 1997, 10:129-136.
38. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
39. Stoica-Nazarov C., Surls J., Bona C., Casares S., Brumeanu T.D. CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message. J Immunol 2009, 182:102-110.
40. Bot A., Casares S., Bot S., von Boehmer H., Bona C. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells. J Immunol 1998, 160:4500-4507.
41. Ahmadzadeh M., Hussain S.F., Farber D.L. Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells. J Immunol 2001, 166:926-935.
42. Bingaman A.W., Patke D.S., Mane V.R., Ahmadzadeh M., Ndejembi M., Bartlett S.T., et al. Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue. Eur J Immunol 2005, 35:3173-3186.
43. Hogan R.J., Zhong W., Usherwood E.J., Cookenham T., Roberts A.D., Woodland D.L. Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med 2001, 193:981-986.
44. + single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 1994, 180:25-34.
45. Walker M.R., Carson B.D., Nepom G.T., Ziegler S.F., Buckner J.H. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci U S A 2005, 102:4103-4108.
46. Thornton A.M., Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000, 164:183-190.
47. Andersson J., Tran D.Q., Marko P., Davidson T.S., Ramsey H., O'Shea J.J., et al. CD4+ Foxp3+ regulatory T cells confer infectious tolerance in TGF-β dependent manner. J Exp Med 2008, 205:1975-1981.
48. Lio C.W., Hsieh C.S. A two-step process for thymic regulatory T cell development. Immunity 2008, 28:100-111.
49. Burchill M.A., Yang J., Vang K.B., Moon J.J., Chu H.H., Lio C.W., et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 2008, 28:112-121.
50. Yu X., Tsibane T., McGraw P.A., House F.S., Keefer C.J., Hicar M.D., et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 445:532-536.
51. Brown D.M., Roman E., Swain S.L. CD4 T cell responses to influenza infection. Seminars Immunol 2004, 16:171-177.
52. Catron D.M., Rusch L.K., Hataye J., Itano A.A., Jenkins M.K. CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells. J Exp Med 2006, 203:1045-1054.
53. Verhoeven D., Teijaro J.R., Farber D.L. Heterogeneous memory T cells in antiviral immunity and immunopathology. Viral Immunol 2008, 21:99-113.
54. Welsh R.M., Selin L.K. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002, 2:417-426.
55. Mozdzanowska K., Maiese K., Gerhard W. Th cell-deficient mice control influenza virus infection more effectively than Th- and B-cell deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J Immunol 2000, 164:2635-2643.
56. Flynn K.J., Belz G.T., Altman J.D., Ahmed R., Woodland D.L., Doherty P.C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 1998, 8:683-691.
57. Strutt T.M., McKinstry K., Swain S.L. Functionally diverse subsets in CD4 T cell responses against influenza. J Clin Immunol 2009, 29:145-150.
58. McKinstry K.K., Golech S., Lee W.H., Huston G., Weng N.P., Swain S.L. Rapid default transition of CD4 T cell effectors to functional memory cells. J Exp Med 2007, 204:2199-2211.
59. Ban Y., Tozaki T., Tobe T., Jacobson E.M., Concepcion E.S., Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 2007, 28:201-207.
60. Moore A.C., Gallimore A., Draper Sj, Watkins K.R., Gilbert S.C., Hill A.V. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol 2005, 175:7264-7273.
61. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002, 3:135-142.
62. Stephens G.L., McHugh R.S., Whitters M.J., Young D.A., Luxenberg D., Carreno B.M., et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004, 173:5008-5020.
63. Liu G., Burns S., Huang G., Boyd K., Proia R.L., Flavell R.A., et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol 2009, 10:769-777.
64. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
65. Yang Y., Huang C.T., Huang X., Pardoll D.M. Persistent toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 2004, 5:508-515.